ClinicalTrials.gov
public full text
Public Domain
Diamel in the Treatment of Metabolic Syndrome
The purpose of this study is to assess the efficacy of Diamel administration in the treatment of Metabolic Syndrome. The duration of this double-blind placebo controlled phase 3 clinical trial will be 12 months.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Evaluation of DIAMEL® Combined With Insulin in Diabetic Foot Ulcer#889766
- Safety and Efficacy Study of Pitavastatin in Patient With a Metabolic Syndrome#982595
- Short, Simple, Exercise to Improve Circadian Dependent Postprandial Glycemic Responses#969638
- Retrospective Analysis for Patients With Metabolic Syndrome#226222
- Naltrexone/Bupropion With or Without Very Low Calorie Ketogenic Diet for Weight Regain After Bariatric Surgery#1075361
Record · ID 872195
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive